SWHR convened an interdisciplinary Autoimmune Policy Working Group to discuss policy needs and opportunities as they relate to women’s autoimmune and immune-mediated diseases and conditions across the lifespan.
This event discusses how to improve health outcomes through recognizing and addressing symptoms, comorbidities, treatment options, and barriers to accessing quality care, while highlighting the diverse experiences of women during and after the menopause transition.
SWHR convened an interdisciplinary Alzheimer’s Disease Policy Working Group of policy experts, researchers, clinicians, and patient advocates for a closed, roundtable meeting in August 2022 to discuss policy needs and opportunities as they relate to improving health and quality of life outcomes in Alzheimer’s disease and related dementias for women.
